Literature DB >> 28578649

Peptides Against Autoimmune Neurodegeneration.

Alexey Stepanov1, Yakov Lomakin1, Alexander Gabibov1, Alexey Belogurov2.   

Abstract

The mammalian immune system is a nearly perfect defensive system polished by a hundred million years of evolution. Unique flexibility and adaptivity have created a virtually impenetrable barrier to numerous exogenous pathogens that are assaulting us every moment. Unfortunately, triggers that remain mostly enigmatic will sometimes persuade the immune system to retarget against self-antigens. This civil war remains underway, showing no mercy and taking no captives, eventually leading to irreversible pathological changes in the human body. Research that has emerged during the last two decades has given us hope that we may have a chance to overcome autoimmune diseases using a variety of techniques to "reset" the immune system. In this report, we summarize recent advances in utilizing short polypeptides - mostly fragments of autoantigens - in the treatment of autoimmune neurodegeneration. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Multiple sclerosis; autoantibodies; autoreactive B cellzzm321990elimination; cross-reactivity; immunotoxins; liposomes; specific allergen immunotherapy; tolerance

Mesh:

Substances:

Year:  2017        PMID: 28578649     DOI: 10.2174/0929867324666170605092221

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  3 in total

1.  Divergent Immunomodulation Capacity of Individual Myelin Peptides-Components of Liposomal Therapeutic against Multiple Sclerosis.

Authors:  Vilena V Ivanova; Svetlana F Khaiboullina; Marina O Gomzikova; Ekaterina V Martynova; André M Ferreira; Ekaterina E Garanina; Damir I Sakhapov; Yakov A Lomakin; Timur I Khaibullin; Evgenii V Granatov; Farit A Khabirov; Albert A Rizvanov; Alexander Gabibov; Alexey Belogurov
Journal:  Front Immunol       Date:  2017-10-16       Impact factor: 7.561

2.  Targeted Drug Delivery in Lipid-like Nanocages and Extracellular Vesicles.

Authors:  A V Sokolov; N N Kostin; L A Ovchinnikova; Y A Lomakin; A A Kudriaeva
Journal:  Acta Naturae       Date:  2019 Apr-Jun       Impact factor: 1.845

Review 3.  Molecular Interventions towards Multiple Sclerosis Treatment.

Authors:  Athanasios Metaxakis; Dionysia Petratou; Nektarios Tavernarakis
Journal:  Brain Sci       Date:  2020-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.